• Phosphatase Inhibitor Cocktail 1: Precision in Phosphoproteo

  2026-07-07

  Explore how Phosphatase Inhibitor Cocktail 1 ensures accurate protein phosphorylation preservation for advanced phosphoproteomic analysis. This article offers a deeper look at mechanistic specificity, experimental design, and translational insights for signaling research.

• Mycophenolic Acid: Precision Modulation of Immune Metabolism

  2026-07-07

  Explore how Mycophenolic acid, a potent dehydrogenase inhibitor, enables nuanced modulation of immune cell metabolism in research. This article reveals deeper mechanistic insights and strategic assay design considerations not covered in standard guides.

• Isoprinosine in Antiviral Immunomodulation: Mechanisms, Evid

  2026-07-06

  Explore the multifaceted role of Isoprinosine (inosine pranobex) in antiviral immunotherapy, with a deep dive into its mechanisms, the latest host-virus interaction research, and advanced protocol guidance for translational virology. Gain unique insights beyond standard workflows, grounded in recent breakthroughs.

• VX-702: Advanced p38α MAPK Inhibitor for Inflammation Models

  2026-07-06

  VX-702 stands out as a highly selective p38α MAPK inhibitor, enabling precision in dissecting inflammatory pathways and protecting tissue in disease models. Its dual-action mechanism, validated by structural studies, provides superior control over cytokine-driven responses and kinase dephosphorylation compared to traditional inhibitors.

• CDK9 Inhibitor (A3294): Technical Protocols and Lab Guidance

  2026-07-05

  The CDK9 inhibitor (A3294) provides researchers with a selective, non-cytotoxic serine/threonine kinase inhibitor for studying transcription elongation and HIV-1 propagation inhibition. It is unsuitable for broad-spectrum CDK inhibition or protocols requiring long-term storage of working solutions. Researchers should apply precise handling and solubility protocols to ensure consistency and specificity.

• Sunitinib: Multi-Targeted RTK Inhibitor for Advanced RCC Res

  2026-07-04

  Sunitinib empowers researchers to dissect and target tumor angiogenesis and resistance mechanisms in renal cell carcinoma with nanomolar potency. This guide translates the latest workflow innovations and troubleshooting strategies into actionable protocols, drawing on new metabolic insights that restore Sunitinib efficacy.

• Dose- and Time-Dependent Neurotoxicity of Ibotenic Acid in M

  2026-07-03

  This study delivers the first systematic in vivo characterization of ibotenic acid’s dose- and time-dependent neurotoxicity in mice, using behavioral, biochemical, and neuronal markers. Its findings provide foundational insights for modeling mushroom poisoning and inform both preclinical research and clinical toxicology.

• Ceftolozane-Tazobactam in Nosocomial Pneumonia: Implications

  2026-07-03

  The reference study details how ceftolozane-tazobactam, through targeted molecular modifications, achieves potent and stable activity against multidrug-resistant Pseudomonas aeruginosa in hospital-acquired pneumonia. Its findings on structure-activity relationships, resistance mechanisms, and PK/PD optimization have direct implications for advancing cephalosporin antibiotic research and benchmarking new compounds for challenging infection models.

• ARL4C Drives Synoviocyte Proliferation in Rheumatoid Arthrit

  2026-07-02

  This study uses multi-dimensional single-cell and bulk transcriptomic analyses to identify ARL4C as a key driver of fibroblast-like synoviocyte (FLS) proliferation and macrophage polarization in rheumatoid arthritis (RA). The findings clarify the molecular mechanisms underlying RA progression and suggest new therapeutic avenues targeting synovial cell proliferation.

• Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-07-02

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers researchers to track mRNA uptake and protein translation in real time using dual fluorescence. Its advanced Cap 1 structure and Cy5 labeling streamline mRNA delivery assays and enhance immune evasion, setting a benchmark for functional genomics and therapeutic development.

• Alpha-Ketoglutarate in Metabolic Reprogramming Workflows

  2026-07-01

  Alpha-ketoglutarate empowers advanced metabolic and immune modulation assays, providing a critical bridge for dissecting tumor microenvironment dynamics and chemotherapy resistance. This guide details cutting-edge workflows, troubleshooting strategies, and protocol nuances, anchored by the latest breakthroughs in enzyme system research.

• Tamsulosin for POUR: Translational Impact and Protocol Optim

  2026-07-01

  Explore how Tamsulosin, a selective α1A-adrenergic antagonist, revolutionizes postoperative urinary retention (POUR) prevention with evidence-backed dosing strategies and translational insights. Discover unique protocol guidance and assay decision-making not covered elsewhere.

• Tunicamycin: Potent N-Glycosylation Inhibitor for ER Stress

  2026-06-30

  Tunicamycin is a crystalline N-glycosylation inhibitor widely used to induce endoplasmic reticulum (ER) stress and dissect protein homeostasis mechanisms. Its efficacy in suppressing inflammation in macrophages and modulating ER stress responses makes it a benchmark reagent for cell biology research.

• Resazurin Sodium Salt: Precision Fluorogenic Indicator for C

  2026-06-30

  Resazurin sodium salt stands out as a premier fluorogenic oxidation-reduction indicator, streamlining cell viability and cytotoxicity workflows across flow cytometry, microscopy, and high-throughput platforms. Its redox sensitivity and versatility make it indispensable for both routine screenings and advanced disease modeling.

• Cyclic di-GMP: Applied Workflows for Biofilm and Immunity Re

  2026-06-29

  Cyclic di-GMP offers dual functionality as a bacterial biofilm regulator and a potent STING pathway agonist in immune modulation research. This article translates cutting-edge findings into actionable workflows, providing troubleshooting guidance and protocol optimization for both infection biology and cancer immunotherapy studies.

450 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page